Joseph Mikhael, M.D. Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen) Discusses Treating Patients Differently: High Risk Vs Standard at Lymphoma & Myeloma on October 18, 2018.
